News

Company News: Curetis Announces Financial Results for the First Six Months of 2017

– Further advancement of product pipeline and integration of GEAR and Gyronimo platforms

– Expansion of global installed base to 161 as of June 30, 2017; 42.5% increase over prior year

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today reported its financial results for the first six months ended June 30, 2017, and provided an update on its financial and business guidance for the second half of 2017 and beyond.

Read more…

Company News: Curetis Announces Management Board Changes

– New roles for Andreas Boos, Chris Bernard and Dr. Achim Plum

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced several changes in its Management Board, effective as of today.

Read more…

Company News: Curetis Partners with Biotest to support academic PEPPER Pentaglobin® Peritonitis Trial with Unyvero IAI Application

— Trial sponsored by University Clinic RWTH Aachen investigates personalized treatment approaches with Biotest’s Pentaglobin® in peritonitis patients

— Curetis to provide testing services for different samples from up to 200 patients with its recently launched Unyvero IAI Application for intra-abdominal infections

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that it has closed a partnership with Biotest AG (Dreieich, Germany). Under the terms of the agreement, Curetis will provide Biotest with in-house testing services using Curetis’ Unyvero IAI cartridge for the diagnosis of intra-abdominal infections. Financial terms were not disclosed.

Read more…

Company News: Curetis to Report its Half-Year Results 2017 on August 16, 2017

– Company will host earnings conference call and webcast

 Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that it will publish its financial results for the first six months ended on June 30, 2017, on August 16, 2017. In addition, the Company will host a public earnings conference call and webcast on August 16, 2017, at 03:00 pm CET / 09:00 am EST to present the H1 2017 financial results, highlight the most important events and provide an outlook for the second half of 2017 and beyond.

Read more…

1 2 113